title: CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease.
abstract: The saturated C20 isoprenoid phytanic acid is physiologically derived from phytol released in the degradation of chlorophyll. The presence of a C-3 methyl group in this substrate blocks normal beta-oxidation, so phytanic acid degradation primarily occurs by initial peroxisomal alpha-oxidation to shift the register of the methyl group. However, individuals with Refsum's disease are genetically deficient in the required phytanoyl-CoA alpha-hydroxylase and suffer from neurological pathologies caused by the accumulation of phytanic acid. Recent work has shown that phytanic acid can also be catabolized by a pathway initiated by omega-hydroxylation of the hydrocarbon chain, followed by oxidation of the alcohol to the acid and conventional beta-oxidation. However, the enzymes responsible for the omega-hydroxylation of phytanic acid have not been identified. In this study, we have determined the activities of all of the rat and human CYP4A enzymes and two of the rat CYP4F enzymes, with respect to the omega-hydroxylation of phytanic acid. Furthermore, we have shown that the ability to omega-hydroxylate phytanic acid is elevated in microsomes from rats pretreated with clofibrate. The results support a possible role for CYP4 enzyme elevation in the elimination of phytanic acid in Refsum's disease patients.
authors.affiliation: Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94143-2280, USA.
authors.forename: Fengyun
authors.initials: F
authors.lastname: Xu
authors.forename: Valerie Y
authors.initials: VY
authors.lastname: Ng
authors.forename: Deanna L
authors.initials: DL
authors.lastname: Kroetz
authors.forename: Paul R Ortiz
authors.initials: PR
authors.lastname: de Montellano
mesh_terms: D000818:Animals; D015153:Blotting, Western; D002994:Clofibrate / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis / Q000378:metabolism*; D004790:Enzyme Induction; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D006900:Hydroxylation; D000960:Hypolipidemic Agents / Q000494:pharmacology; D007527:Isoenzymes / Q000096:biosynthesis / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D010084:Oxidation-Reduction; D010831:Phytanic Acid / Q000378:metabolism*; D051381:Rats; D011916:Rats, Inbred F344; D012035:Refsum Disease / Q000201:enzymology*; D013379:Substrate Specificity
chemical_list: D000960:Hypolipidemic Agents; D007527:Isoenzymes; D010831:Phytanic Acid; D003577:Cytochrome P-450 Enzyme System; D002994:Clofibrate